oral
oncolog
journal
homepag
wwwelseviercomlocateoraloncolog
letter
editor
consider
povidoneiodin
public
health
intervent
util
person
protect
equip
frontlin
provid
expos
highrisk
head
neck
skull
base
oncolog
care
respons
novel
coronaviru
healthcar
system
challeng
alloc
scarc
resourc
strive
achiev
distribut
justic
meet
critic
need
commun
serv
though
ongo
random
trial
evalu
util
system
therapi
postconvalesc
serum
vaccin
develop
intervent
costli
time
intens
altern
therapi
prevent
measur
need
acceler
flatten
epidemiolog
curv
also
safeguard
provid
patient
reevalu
tier
surgic
respons
oper
process
move
forward
earli
investig
china
suggest
cancer
patient
harbor
higher
risk
infect
compar
overal
popul
infect
cancer
patient
particularli
receiv
chemotherapi
underw
surgeri
within
month
infect
suscept
need
critic
care
respiratori
support
mortal
viral
hotspot
wuhan
nosocomi
spread
suspect
patient
health
profession
tertiari
care
institut
citi
infect
popul
healthcar
worker
find
suggest
patient
malign
vulner
popul
increas
infect
risk
healthcar
provid
front
line
viral
load
appear
highest
nasopharynx
high
human
saliva
anatom
area
like
seed
lower
airway
serv
one
main
reservoir
aerosol
transmiss
progress
pulmonari
diseas
furthermor
viral
load
asymptomat
symptomat
patient
similar
suggest
transmiss
potenti
asymptomaticminim
symptomat
patient
head
neck
oncologist
skull
base
surgeon
among
highest
risk
nosocomi
transmiss
first
describ
case
albeit
anecdot
operativerel
spread
occur
endoscop
pituitari
surgeri
wuhan
wherein
fourteen
personnel
becam
infect
pervas
dynam
tension
respons
flatten
curv
commit
hippocrat
oath
first
harm
recogn
delay
cancer
treatment
influenc
diseas
outcom
protect
patient
tri
equilibr
tension
respons
question
delug
suggest
procedur
guidelin
reduc
aerosol
descript
appropri
ppe
among
approach
povidoneiodin
pvpi
wide
avail
topic
broad
spectrum
antisept
suggest
nasal
oral
applic
periop
infect
control
strategi
util
excel
safeti
profil
topic
nasal
oral
solut
pvpi
long
recogn
especi
dilut
concentr
eg
detail
review
virucid
activ
wide
rang
common
virus
includ
sarscov
merscov
coronavirus
beyond
scope
articl
word
caution
vitro
studi
use
pvpi
demonstr
cilotox
human
respiratori
cell
howev
investig
demonstr
continu
virucid
effect
dilut
pvpi
concentr
without
evid
respiratori
cilia
toxic
diminish
olfactori
function
chang
mucos
appear
vitro
studi
pvpi
mouthwash
dilut
inactiv
sarscov
merscov
follow
exposur
though
rare
prolong
use
topic
pvpi
solut
weeksmonth
may
increas
risk
iodin
toxic
allergi
contact
sensit
skin
reaction
rare
present
novel
intervent
strategi
util
topic
applic
pvpi
attenu
nosocomi
transmiss
surround
head
neck
skull
base
oncolog
care
given
frontlin
provid
expos
open
endoscop
upper
aerodigest
procedur
may
serv
vector
transmiss
protocol
identifi
healthcar
worker
potenti
target
popul
treatment
intervent
especi
highpreval
area
given
increas
penetr
nasopharynx
larg
volum
nasal
irrig
aim
incorpor
chronic
rhinosinus
treatment
model
propos
follow
formul
administr
nasal
irrig
ml
pvpi
solut
dilut
ml
commerci
avail
aqueou
pvpi
ml
normal
salin
sinu
rins
deliveri
bottl
oraloropharyng
wash
ml
aqueou
pvpi
solut
dilut
steril
distil
water
addit
appropri
ppe
certainli
literatur
support
safeti
dosag
higher
concentr
pvpi
may
welltoler
without
mucociliari
toxic
recommend
lower
concentr
abund
caution
moreov
though
nasal
irrig
may
yield
increas
discomfort
compar
atom
spray
deliveri
mode
decreas
theoret
risk
aerosol
viral
particl
follow
outlin
stratifi
treatment
approach
strategi
benefit
broad
avail
materi
excel
safeti
profil
associ
low
cost
given
eas
acquir
materi
healthcar
provid
may
immedi
implement
intervent
form
person
protect
equip
augment
current
practic
recommend
import
acknowledg
potenti
risk
prophylact
treatment
healthcar
provid
could
increas
suscept
infect
affect
mucociliari
function
local
immun
previous
mention
worth
restat
recommend
lower
concentr
abund
caution
minim
untest
possibl
though
describ
protocol
context
frontlin
provid
care
head
neck
skull
base
patient
strategi
may
appli
addit
practition
occup
exposur
let
us
flatten
epidemiolog
curv
keep
commit
first
harm
author
declar
conflict
interest
